NO20011406D0 - Immunogene liposompreparater - Google Patents

Immunogene liposompreparater

Info

Publication number
NO20011406D0
NO20011406D0 NO20011406A NO20011406A NO20011406D0 NO 20011406 D0 NO20011406 D0 NO 20011406D0 NO 20011406 A NO20011406 A NO 20011406A NO 20011406 A NO20011406 A NO 20011406A NO 20011406 D0 NO20011406 D0 NO 20011406D0
Authority
NO
Norway
Prior art keywords
liposome preparations
immunogenic liposome
immunogenic
preparations
liposome
Prior art date
Application number
NO20011406A
Other languages
English (en)
Other versions
NO330685B1 (no
NO20011406L (no
Inventor
Gary Fujii
Donald V Cramer
William A Ernst
Jill Adler-Moore
L Jeanne Perry
Original Assignee
Molecular Express Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Express Inc filed Critical Molecular Express Inc
Publication of NO20011406D0 publication Critical patent/NO20011406D0/no
Publication of NO20011406L publication Critical patent/NO20011406L/no
Publication of NO330685B1 publication Critical patent/NO330685B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20011406A 1998-09-22 2001-03-20 Immunogene liposompreparat samt fremgangsmate for fremstilling av dette NO330685B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21
PCT/US1999/020880 WO2000016746A2 (en) 1998-09-22 1999-09-22 Immunogenic liposome compositions

Publications (3)

Publication Number Publication Date
NO20011406D0 true NO20011406D0 (no) 2001-03-20
NO20011406L NO20011406L (no) 2001-04-24
NO330685B1 NO330685B1 (no) 2011-06-06

Family

ID=26798150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011406A NO330685B1 (no) 1998-09-22 2001-03-20 Immunogene liposompreparat samt fremgangsmate for fremstilling av dette

Country Status (31)

Country Link
EP (1) EP1115382B1 (no)
JP (1) JP2002526436A (no)
KR (1) KR100592825B1 (no)
CN (1) CN1555254A (no)
AP (1) AP2010A (no)
AT (1) ATE468108T1 (no)
AU (1) AU766772B2 (no)
BG (1) BG65675B1 (no)
BR (1) BR9914004A (no)
CA (1) CA2344173C (no)
CY (1) CY1110718T1 (no)
CZ (1) CZ20011013A3 (no)
DE (1) DE69942393D1 (no)
DK (1) DK1115382T3 (no)
EA (1) EA004797B1 (no)
EE (1) EE200100168A (no)
ES (1) ES2345695T3 (no)
GE (1) GEP20053444B (no)
HK (1) HK1039064A1 (no)
HU (1) HUP0105391A3 (no)
ID (1) ID29082A (no)
IL (2) IL141675A0 (no)
MX (1) MXPA01002973A (no)
NO (1) NO330685B1 (no)
NZ (2) NZ510442A (no)
OA (1) OA11657A (no)
PL (1) PL206260B1 (no)
SK (1) SK287670B6 (no)
UA (1) UA75327C2 (no)
WO (1) WO2000016746A2 (no)
ZA (1) ZA200101829B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110831A2 (en) 2005-04-12 2006-10-19 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
JP2014518620A (ja) 2011-04-26 2014-08-07 モレキュラー エクスプレス，インコーポレイテッド リポソーム製剤
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
JP2020515629A (ja) * 2017-04-04 2020-05-28 アヴィディア テクノロジーズ， インコーポレイテッド 免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
US4861597A (en) * 1986-05-20 1989-08-29 Wako Pure Chemical Industries, Ltd. Novel functionallized liposomes and a process for production thereof
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
AP2001002096A0 (en) 2001-03-31
ATE468108T1 (de) 2010-06-15
KR20010075261A (ko) 2001-08-09
EA200100269A1 (ru) 2001-12-24
IL141675A (en) 2007-06-17
AU6035199A (en) 2000-04-10
SK3222001A3 (en) 2001-09-11
UA75327C2 (en) 2006-04-17
EP1115382A2 (en) 2001-07-18
SK287670B6 (sk) 2011-05-06
AP2010A (en) 2009-06-29
CA2344173A1 (en) 2000-03-30
BG65675B1 (bg) 2009-06-30
DE69942393D1 (de) 2010-07-01
NO330685B1 (no) 2011-06-06
JP2002526436A (ja) 2002-08-20
KR100592825B1 (ko) 2006-06-23
EP1115382B1 (en) 2010-05-19
AU766772B2 (en) 2003-10-23
CA2344173C (en) 2010-02-23
NZ510442A (en) 2003-10-31
PL206260B1 (pl) 2010-07-30
NO20011406L (no) 2001-04-24
DK1115382T3 (da) 2010-09-06
HUP0105391A2 (hu) 2002-05-29
WO2000016746A2 (en) 2000-03-30
MXPA01002973A (es) 2003-03-27
EA004797B1 (ru) 2004-08-26
ID29082A (id) 2001-07-26
ES2345695T3 (es) 2010-09-29
HK1039064A1 (en) 2002-04-12
NZ528055A (en) 2005-01-28
EE200100168A (et) 2002-06-17
WO2000016746A9 (en) 2000-09-21
CY1110718T1 (el) 2015-06-10
GEP20053444B (en) 2005-02-25
CZ20011013A3 (cs) 2002-03-13
BG105372A (en) 2001-10-31
ZA200101829B (en) 2002-06-05
IL141675A0 (en) 2002-03-10
WO2000016746A3 (en) 2000-11-23
BR9914004A (pt) 2001-07-24
WO2000016746A8 (en) 2000-08-10
PL348604A1 (en) 2002-06-03
OA11657A (en) 2004-12-08
HUP0105391A3 (en) 2006-02-28
CN1555254A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
IS6040A (is) Valdekoxib efnablöndur
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
DK1210113T3 (da) Kombinerede vaccinepræparater
DE69938817D1 (de) Erstellungsverfahren
DK1100469T3 (da) Hurtigt henfaldende fast præparat
DE69931855D1 (de) Hautpräparat
DE59902101D1 (de) Pigmentpräparationen
DE69906737T2 (de) Mischvorrichtung
DK0988861T3 (da) Stabiliserede proteinpræparater
EP1154755A4 (en) Liposomes FORMULATIONS
DK0974399T3 (da) Rotordyse
DK1109450T3 (da) Mikrokapselpræparater
DE59707298D1 (de) Desodorierende zubereitungen
DE59901642D1 (de) Sonnenschutzmittel
ATE246494T1 (de) Brausezubereitungen
DE69926012D1 (de) Arzneizubereitungen
NO20005599L (no) Vaksine
DE59908817D1 (de) Wässrige zubereitungen
DE59909255D1 (de) Kosmetische zubereitungen
NO20011406D0 (no) Immunogene liposompreparater
HUP0200483A3 (en) Liposome preparations
DE50009295D1 (de) Vernetzerfreie zubereitungen
IS5879A (is) Ný efnablanda
ID23663A (id) Persiapan kaprolaktam

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees